Enrolling By Invitation EARLY_PHASE1 INTERVENTIONAL 3-arm
NCT07023848
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Sponsor: Affiliated Hospital of Jiangnan University
Interventions
18F-FDG 89Zr-LNCab103 89Zr-LNCab104
Updated 1 time since 2025 Last updated: Jun 14, 2025 Started: Jul 1, 2025 Primary completion: Jul 7, 2026 Completion: Dec 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07023848, this EARLY_PHASE1 trial focuses on Breast Cancer and Gastric Cancer (GC) and remains ongoing. Sponsored by Affiliated Hospital of Jiangnan University, it has been updated 1 time since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Enrolling By Invitation — EARLY_PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Affiliated Hospital of Jiangnan University
Data source: Affiliated Hospital of Jiangnan University
For direct contact, visit the study record on ClinicalTrials.gov .